Evidence map›Paper›PMID 18466519›Full record

ArticleBMC proceedings2007

Dealing with missing phase and missing data in phylogeny-based analysis.

Claire Bardel, Pascal Croiseau, Emmanuelle Génin

Abstract read
In one paragraph

Article in BMC proceedings, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Claire BardelUMR 5145 - Génétique des Populations Humaines - CNRS MNH, Université Paris VII, 17 Place du Trocadero, Paris, 75016 France. bardel@vjf.inserm.fr
Pascal Croiseau
Emmanuelle Génin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently described a new method to identify disease susceptibility loci, based on the analysis of the evolutionary relationships between haplotypes of cases and controls. However, haplotypes are often unknown and the problem of phase inference is even more crucial when there are missing data. In this work, we suggest using a multiple imputation algorithm to deal with missing phase and missing data, prior to a phylogeny-based analysis. We used the simulated data of Genetic Analysis Workshop 15 (Problem 3, answer known) to assess the power of the phylogeny-based analysis to detect disease susceptibility loci after reconstruction of haplotypes by a multiple-imputation method. We compare, for various rates of missing data, the performance of the multiple imputation method with the performance achieved when considering only the most probable haplotypic configurations or the true phase. When only the phase is unknown, all methods perform approximately the same to identify disease susceptibility sites. In the presence of missing data however, the detection of disease susceptibility sites is significantly better when reconstructing haplotypes by multiple imputation than when considering only the best haplotype configurations.

Identifiers

PMID18466519
PMCPMC2367603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.